Summarized by Masters of Longevity from PR Newswire.
A preview of a planned large-scale single-cell immune profiling project that will add a high-resolution immune data layer to a major population biobank, outlining scope and collaborative platforms involved.
Key Takeaways
- The study will profile an initial 80,000 UK Biobank blood samples using single-cell multiomics and sequencing platforms.
- Ultima Genomics' UG200 sequencer was selected and validated for use with the BD Rhapsody single-cell platform for this project.
- Project aims to expand immune profiling across UK Biobank's full cohort and return data to approved researchers for downstream study.
